VVUS and OREX Related Headlines

Go Back

Sep 11, 2014 09:19AM Orexigen Therapeutics (OREX) Price Target Raised to $14-$15 at Wells Fargo
Sep 11, 2014 08:58AM VIVUS (VVUS), Arena (ARNA) Active Following FDA Approval of Orexigen's (OREX) Weight-Loss Drug
Aug 1, 2014 11:53AM Arena Pharma (ARNA) Peers Drop in Sympathy Following Q2 Results (OREX) (VVUS)
Jul 7, 2014 11:56AM Arena Pharma (ARNA) Peers Trade Lower in Sympathy (OREX) (VVUS)
Jun 11, 2014 08:03AM Wells Fargo Comments on Orexigen Therapeutics (OREX) PDUFA Data Change
Feb 24, 2014 05:32PM Orexigen (OREX), Arena (ARNA) in Focus Following VIVUS' (VVUS) Q4 Results
Jan 10, 2014 02:34PM WallachBeth Starts Orexigen (OREX) at Buy; Sees Contrave With Edge Over Peers (ARNA) (VVUS)
Dec 30, 2013 07:57AM VIVUS, Inc. (VVUS) Sees CHMP Feedback on Qsiva Resubmission as 'Generally Positive'

VVUS and OREX Related Press Releases

Go Back

VVUS and OREX Related SEC Filings

Go Back

Dec 30, 2013 07:57AM VIVUS, Inc. (VVUS) Sees CHMP Feedback on Qsiva Resubmission as 'Generally Positive'